SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AGNSS Recommends Alexion Pharmaceuticals Inc.'s Soliris® (eculizumab) for aHUS and Concludes "Eculizumab Would Help Save Lives and Improve the Quality of Life for Children and Adults With Atypical Haemolytic Uraemic Syndrome"